Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Researchers identify potential nanotechnology therapy for rare, incurable bone cancer
Newer Targets
DCprime Presents Comprehensive Preclinical Results Supporting Lead Clinical Candidate DCP-001
Newer Targets
Regeneration mechanism discovered in mice could provide target for drugs to…
Newer Targets
New Study Demonstrates a Unique Role of Nicotinamide Riboside Over Other…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase III
resTORbio Halts Respiratory Program for RTB101 After Phase III Failure
Phase III
Everest Medicines Achieved First Patient Dosing Milestone in Etrasimod Phase 3…
Clinical
FDA In Brief: FDA issues final guidance for development of smallpox…
Approval
US clears Novartis’ anti-P-selectin antibody Adakveo to reduce rate of sickle…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Adding Terlipressin to Albumin Therapy Boosts Reversal of Hepatorenal Syndrome: Presented…
Deals
BIOCORP Signs Exclusive Deal With VITROBIO PHARMA to Produce the First…
Deals
FTC okays Bristol-Myers Squibb’s Celgene takeover
Deals
Fosun Pharma and MimiVaxHave Signed Exclusive License for Fosun Pharma to…
Home
Therapy areas
Therapy areas
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Cardio-metabolism
Andexxa Highlighted as a First-Line Factor Xa Reversal Option by the American College of Emergency Physicians
Firstwordpharma News
-
November 15, 2019
Others
BioSpace Movers & Shakers, Nov. 15
Others
BioSpace Global Roundup, Nov. 14
Others
Mylan Manufacturing Site Flagged for Poor Controls Over Valsartan Production
Others
Teva Changes Mind, Will Manufacture Childhood Chemotherapy Drug
Others
Which 15 Biopharma Employers are Leading in Opportunities for Promotion?
Biospace News
-
November 14, 2019
0
Others
Bioasis Announces Issuance of Japanese Patent Relating to xB3 Platform Technology...
Firstwordpharma News
-
November 14, 2019
0
Others
NIH, NIST researchers use artificial intelligence for quality control of stem...
Firstwordpharma News
-
November 14, 2019
0
Immuno-oncology
Clinical Efficacy of Weekly ONC201 in Adult Recurrent Glioblastoma Published
Firstwordpharma News
-
November 13, 2019
0
Others
Dartmouth Study Assesses Fracture Risk for Patients Taking Multiple Medications
Firstwordpharma News
-
November 13, 2019
0
1
2
3
...
222
Page 1 of 222
- Advertisement -
MOST POPULAR
Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol...
March 1, 2019
Together with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian...
February 6, 2019
Protagonist Therapeutics to Present at the H.C. Wainwright & Co. Global...
April 1, 2019
BioSpace’s Hot 8 Life Science Locations for Jobs
April 9, 2019
Load more
HOT NEWS
Deals
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
Commercial
Endo International plc Announces Early Tender Results of its Previously Announced...
Commercial
Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member
Others
Regeneron’s Eylea granted expanded US approval for diabetic retinopathy
